Companies
Search, filter and compare every US company we cover.
Sector
All sectors
No matches for ββ.
Industry
All industries
Communication Services
Consumer Discretionary
Consumer Staples
Energy
Financials
Health Care
Industrials
Information Technology
Materials
Real Estate
Utilities
No matches for ββ.
Size
Any size
No matches for ββ.
Today
Up or down
No matches for ββ.
Add filter
Size
Growth
Margins
Returns
Debt and payouts
Valuation and quality
Insiders
No matches for ββ.
Market cap
Price
Day change
Revenue
Revenue growth
Operating margin
P/E
5-yr growth
Gross margin
Net margin
Free cash flow
FCF margin
Return on capital
Return on equity
Net debt
Net debt / EBITDA
Dividends + buybacks
Share count change
F-score
Insider buys (90d)
Insider sales (90d)
| Company | Industry | Market cap | Price | Day change | Revenue | Revenue growth | Operating margin | P/E | 5-yr growth | Gross margin | Net margin | Free cash flow | FCF margin | Return on capital | Return on equity | Net debt | Net debt / EBITDA | Dividends + buybacks | Share count change | F-score | Insider buys (90d) | Insider sales (90d) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bottled & Canned Soft Drinks & Carbonated Waters | $91.9M | $1.28 | 4.9% | $161M | 4.0% | β7.3% | β | 7.9% | 48.0% | β6.2% | β$5.0M | β3.1% | β | β17.1% | β | β | β | 12.5% | 4 | $0.0M | $0.0M | |
| Services-Educational Services | $92.0M | $1.61 | 2.1% | $9.5M | 0.8% | 1.2% | 68.2x | β | 54.8% | 14.4% | β$0.5M | β4.9% | 1.1% | 18.1% | $2.4M | 12.5x | β | 0.9% | 6 | $0.0M | $0.0M | |
| Industrial Organic Chemicals | $92.2M | $1.30 | 8.3% | $198M | β26.2% | β18.8% | β | 3.6% | β0.4% | β39.0% | β$22.7M | β11.5% | β42.0% | β | $380M | β | β | 30.7% | 3 | $0.0M | $0.0M | |
| Pharmaceutical Preparations | $92.4M | $3.94 | 4.8% | $7.9M | 123.6% | β283.9% | β | β | β | β267.1% | β | β | β | β51.4% | β | β | β | 9.8% | 2 | $0.0M | $0.0M | |
| Services-Prepackaged Software | $92.8M | $3.17 | 2.8% | $304M | 2.4% | 10.0% | β | 8.8% | β | β5.6% | $16.3M | 5.4% | 7.9% | β | $338M | 4.1x | $0.4M | β0.5% | 5 | $0.0M | $0.0M | |
| Services-Business Services, Nec | $93.0M | $2.69 | 5.5% | $452M | β18.0% | β8.5% | β | β6.4% | 37.5% | β9.0% | $0.6M | 0.1% | β | β21.5% | β | β | $9.4M | 1.5% | 3 | $0.0M | $0.0M | |
| Services-Prepackaged Software | $93.0M | $7.86 | 1.4% | $78.1M | 6.9% | 8.9% | 31.4x | 7.3% | 50.1% | 3.8% | $11.9M | 15.2% | 36.3% | 7.4% | β$26.7M | β3.3x | β | 2.2% | 4 | $0.0M | $0.0M | |
| Insurance Agents, Brokers & Service | $93.5M | $1.13 | 0.0% | $55.0M | 24.2% | β25.4% | β | β | 61.3% | β40.9% | β$21.3M | β38.7% | β | β | $26.7M | β | β | 10.9% | 5 | $0.0M | $0.0M | |
| State Commercial Banks | $93.8M | $26.86 | 1.5% | $0.6M | 0.8% | β | 11.1x | 1.1% | β | 1,172.1% | $10.9M | 1,755.1% | β | 8.5% | β | β | β | 0.0% | β | $0.0M | $0.0M | |
| Real Estate Investment Trusts | $94.1M | $2.56 | 0.8% | $23.3M | β32.5% | β | 11.6x | β | 60.2% | 29.8% | β | β | β | 3.0% | $91.3M | β | $28.7M | 13.1% | 4 | $0.0M | $0.0M | |
| In Vitro & In Vivo Diagnostic Substances | $94.2M | $10.25 | 1.8% | $27.6M | 4.3% | 6.0% | 146.4x | 12.5% | 41.4% | β3.8% | $1.2M | 4.4% | 4.0% | β3.8% | $5.3M | 1.2x | β | 10.5% | 7 | $0.0M | $0.0M | |
| Orthopedic, Prosthetic & Surgical Appliances & Supplies | $95.3M | $9.59 | 3.9% | $193M | 70.7% | β8.1% | β | 3.9% | 32.9% | β13.1% | β$16.4M | β8.5% | β8.3% | β18.4% | $17.9M | β | $1.2M | 24.4% | 2 | $0.0M | $0.0M | |
| Finance Services | $95.5M | $1.18 | 0.8% | $3.9M | 18.1% | β6,772.6% | β | β | β | β6,825.1% | β | β | β | β280.8% | β | β | $18.9M | 519.4% | 1 | $0.0M | $0.0M | |
| Laboratory Apparatus & Furniture | $95.8M | $32.79 | 1.3% | $282M | 17.3% | 5.9% | 11.9x | 13.8% | 28.5% | 3.4% | $14.7M | 5.2% | 15.0% | 13.8% | $10.6M | 0.5x | $0.0M | 0.1% | 5 | $0.0M | $0.0M | |
| State Commercial Banks | $96.2M | $16.70 | 0.1% | $1.1M | β7.5% | β | 12.7x | β51.1% | β | 525.6% | $9.1M | 796.8% | β | 5.9% | β$62.6M | β | $3.4M | β1.9% | 5 | $0.1M | $0.0M | |
| Pharmaceutical Preparations | $96.4M | $17.08 | 15.0% | β | β | β | β | β | β | β | β$20.5M | β | β | β74.0% | β | β | β | 0.4% | β | $0.0M | $0.0M | |
| Pharmaceutical Preparations | $96.5M | $16.64 | 1.5% | $0.9M | 34.9% | β3,853.6% | 2.6x | β | β | β1,046.4% | β | β | β | β15.0% | β | β | β | 3.4% | 3 | $0.0M | $0.0M | |
| Electromedical & Electrotherapeutic Apparatus | $96.7M | $1.11 | 1.8% | $0.0M | β | β | β | β | β | β | β$25.5M | β | β | β159.6% | β | β | β | 13.5% | 1 | $0.0M | $0.0M | |
| National Commercial Banks | $96.8M | $0.82 | 3.0% | $29.6M | 4.2% | β | 10.3x | 2.5% | β | β42.9% | β$14.3M | β48.4% | β | β25.7% | β$191M | β | $0.0M | 1,831.8% | 2 | $0.1M | $0.0M | |
| Real Estate Investment Trusts | $96.8M | $1.41 | 1.4% | $704M | β3.3% | 10.3% | β | 25.4% | β | β3.2% | β | β | 5.1% | β11.8% | $979M | 5.9x | $48.1M | 1.7% | 3 | $0.0M | $0.0M | |
| Services-Membership Sports & Recreation Clubs | $97.7M | $1.96 | 0.0% | $3.0M | β10.1% | β148.6% | β | β | β | β124.0% | β$3.1M | β104.7% | β | β21.8% | β | β | β | 27.4% | 2 | $0.0M | $0.0M | |
| Services-Business Services, Nec | $98.2M | $0.13 | 1.2% | $39.1M | 1,361.8% | β83.1% | β | 74.7% | 77.8% | β202.1% | β$24.0M | β61.4% | β | β48.8% | β | β | β | 3,535.2% | 5 | $0.0M | $0.0M | |
| Radiotelephone Communications | $98.9M | $1.16 | 3.6% | $3.4M | β27.6% | β827.7% | β | 13.4% | β168.2% | β871.0% | β$26.3M | β778.0% | β | β79.5% | β | β | β | 407.6% | 3 | $0.0M | $0.0M | |
| Public Bldg & Related Furniture | $99.0M | $6.29 | 0.3% | $200M | β25.0% | 1.8% | β | 5.5% | 40.7% | 1.3% | β$6.7M | β3.4% | 2.8% | 2.4% | β$10.5M | β1.1x | $5.6M | β3.7% | 3 | $0.0M | $0.0M | |
| Biological Products, (No Diagnostic Substances) | $99.1M | $3.16 | 2.8% | $19.1M | β | β477.5% | β | β | 97.8% | β430.3% | β$70.0M | β366.7% | β | β33.6% | β | β | β | 35.4% | 2 | $0.0M | $0.0M | |
| Silver Ores | $99.5M | $1.14 | 2.7% | $0.0M | β100.0% | β | 1.8x | β | β | β | β | β | β37.9% | 718.3% | β$71.2M | β | β | 13.0% | 4 | $0.0M | $0.0M | |
| Savings Institution, Federally Chartered | $99.9M | $11.26 | 0.5% | $0.2M | 18.7% | β | β | β15.2% | β | β13,475.5% | β$0.0M | β7.1% | β | β9.1% | β | β | β | β0.5% | β | $0.0M | $0.0M | |
| Motor Vehicle Parts & Accessories | $100M | $2.88 | 4.3% | $649M | β10.3% | β0.1% | β | β2.0% | 10.5% | β3.5% | $34.0M | 5.2% | β0.2% | β16.9% | $74.5M | 5.3x | β | 1.3% | 6 | $0.0M | $0.0M | |
| Services-Prepackaged Software | $101M | $8.08 | 0.2% | $40.3M | 14.5% | β4.5% | β | 14.5% | 78.3% | β7.6% | $4.7M | 11.7% | β11.2% | β43.2% | $8.1M | 4.7x | $4.6M | 4.4% | 4 | $0.0M | $0.0M | |
| Textile Mill Products | $101M | $5.48 | 0.2% | $531M | β7.0% | β2.8% | β | β4.5% | 5.7% | β4.6% | $21.5M | 4.1% | β3.9% | β10.2% | $76.0M | 8.1x | $0.0M | 1.0% | 6 | $0.0M | $0.0M | |
| Finance Services | $101M | $3.71 | 1.3% | $11.4M | 442.3% | β319.7% | β | β | 97.8% | β648.1% | β$18.0M | β157.8% | β13.2% | β143.6% | $118M | β | $11.5M | 89.0% | 2 | $0.3M | $0.0M | |
| Miscellaneous Electrical Machinery, Equipment & Supplies | $101M | $6.07 | 1.8% | $191M | 16.2% | β3.1% | β | 12.2% | 24.1% | β3.1% | $7.1M | 3.7% | β2.7% | β4.5% | $40.3M | β | β | β0.7% | 5 | $0.0M | $0.0M | |
| Services-Offices & Clinics Of Doctors Of Medicine | $102M | $2.13 | 1.8% | $194M | 25.3% | β4.0% | 8.5x | 39.1% | 85.7% | 7.4% | $6.4M | 3.3% | β | 204.0% | β | β | $3.4M | 9.5% | 5 | $0.0M | $0.0M | |
| Biological Products, (No Diagnostic Substances) | $102M | $0.44 | 5.4% | $2.0M | β | β5,306.0% | β | β | β376.1% | β2,003.6% | β$106M | β5,197.5% | β | β | $14.3M | β | β | 33.5% | 3 | $0.0M | $0.0M | |
| Electromedical & Electrotherapeutic Apparatus | $102M | $1.02 | 2.2% | $32.4M | 20.3% | β68.3% | β | 4.0% | 52.7% | β66.8% | β$13.8M | β42.6% | β | β221.3% | β | β | $0.0M | 6.8% | 4 | $0.0M | $0.0M | |
| Pharmaceutical Preparations | $102M | $2.99 | 7.6% | β | β | β | β | β | β | β | β | β | β | β62.2% | β | β | β | 1.9% | β | $0.3M | $0.0M | |
| Services-Medical Laboratories | $102M | $2.03 | 0.5% | $0.1M | 5.2% | β45,066.7% | β | 26.5% | β102.5% | β39,417.3% | β$26.3M | β32,529.6% | β | β51.8% | β | β | β | 43.7% | 2 | $0.0M | $0.1M | |
| Gold And Silver Ores | $103M | $2.87 | 6.5% | β | β | β | β | β | β | β | β$11.5M | β | β | β157.8% | β$23.6M | β | β | 49.0% | β | $0.0M | $0.0M | |
| Patent Owners & Lessors | $103M | $7.21 | 2.2% | $54.9M | 5.2% | β1.7% | 26.7x | β1.3% | 79.6% | 5.3% | $0.3M | 0.6% | β | 16.3% | β | β | $11.3M | 0.3% | 6 | $0.0M | $0.0M | |
| Crude Petroleum & Natural Gas | $103M | $2.51 | 5.9% | $25.0M | 1,663.1% | 11.6% | 13.2x | β | β | 11.5% | β | β | β | 5.3% | β | β | β | 6.1% | 5 | $0.0M | $0.0M | |
| Search, Detection, Navigation, Guidance, Aeronautical Sys | $103M | $9.16 | 0.4% | $26.6M | 30.7% | 17.1% | 20.4x | 5.8% | 66.5% | 15.5% | $6.0M | 22.7% | β | 7.4% | β | β | β | β0.3% | 6 | $0.0M | $0.0M | |
| In Vitro & In Vivo Diagnostic Substances | $104M | $2.83 | 0.4% | $4.1M | 115.6% | β1,260.8% | β | 27.2% | 56.7% | β1,238.5% | β$25.4M | β625.6% | β | β | β | β | β | 133.2% | 3 | $0.0M | $0.0M | |
| Pharmaceutical Preparations | $105M | $3.89 | 1.3% | β | β | β | β | β | β | β | β$31.3M | β | β | β141.1% | β | β | β | 137.2% | β | $0.0M | $0.0M | |
| Biological Products, (No Diagnostic Substances) | $105M | $1.74 | 6.5% | $40.4M | β49.5% | β326.6% | β | β25.1% | β | β296.5% | β$135M | β334.5% | β | β48.3% | β | β | β | 1.8% | 1 | $0.0M | $0.0M | |
| Semiconductors & Related Devices | $106M | $1.29 | 7.2% | $2.9M | β68.6% | β1,274.9% | β | β | β63.4% | β1,513.3% | β$33.1M | β1,154.4% | β | β | $62.0M | β | β | 30.1% | 1 | $0.0M | $0.0M | |
| Oil & Gas Field Services, Nec | $107M | $7.70 | 0.5% | $562M | 1.4% | 0.4% | β | 12.6% | β | β9.1% | β$23.3M | β4.1% | 0.9% | β | $329M | 12.9x | β | 10.1% | 2 | $0.0M | $0.0M | |
| Pharmaceutical Preparations | $108M | $1.68 | 1.8% | $13.9M | β14.2% | β609.2% | β | β | 82.8% | β574.5% | β$63.5M | β458.3% | β | β91.4% | β | β | β | 6.3% | 2 | $0.0M | $0.0M | |
| Biological Products, (No Diagnostic Substances) | $108M | $1.88 | 9.6% | $70.0M | β | 17.9% | β | β | β | 32.0% | β | β | β | 22.9% | β | β | β | 4.6% | 6 | $0.0M | $0.0M | |
| Agricultural Chemicals | $108M | $1.41 | 0.7% | $3.6M | β14.6% | β2,680.1% | β | β31.3% | β | β3,492.3% | β$51.2M | β1,406.1% | β619.7% | β223.0% | β$9.4M | β | β | 97.0% | 3 | $0.0M | $0.0M | |
| Biological Products, (No Diagnostic Substances) | $109M | $1.56 | 1.3% | β | β | β | 0.6x | β | β | β | β$101M | β | β | β53.3% | β | β | β | 35.3% | β | $0.0M | $0.0M |
What do these columns mean?
- Market cap
- Last close times the latest diluted share count, so it is approximate.
- Price
- Closing share price on the last trading day.
- Day change
- Change in the closing price against the previous trading day's close.
- Revenue
- Total sales reported in the income statement.
- Revenue growth
- Change in revenue against the year (or quarter) a year earlier.
- Operating margin
- Operating income as a share of revenue.
- P/E
- Last close divided by diluted earnings per share over the last four quarters.
- 5-yr growth
- Revenue growth a year, compounded over the last five years.
- Gross margin
- Gross profit as a share of revenue.
- Net margin
- Net income as a share of revenue.
- Free cash flow
- Cash from operations minus capital spending.
- FCF margin
- Free cash flow as a share of revenue.
- Return on capital
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
- Return on equity
- Net income as a share of average shareholders' equity.
- Net debt
- Debt and finance leases minus cash and short-term investments. Negative means net cash.
- Net debt / EBITDA
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Dividends + buybacks
- Cash returned to shareholders through dividends and share repurchases.
- Share count change
- Change in the diluted share count. Negative means buybacks shrank it.
- F-score
- Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
- Industry
- The industry the company reports under, from its SEC filing code. Click it to see its peers.
- Colours and dashes
- Green is up or growing, red is down or shrinking. β means no data, or a P/E that is not meaningful (losses, or above 200).
- Units
- M = millions, B = billions, T = trillions, in USD. Fundamentals use the latest fiscal year. Use βEdit columnsβ to show more figures, hide some or change their order.

















































